Topical analgesic creams containing methyl salicylate, menthol, and capsaicin are widely used for musculoskeletal pain management. However, incorporating multiple active ingredients with different lipophilicity and volatility compromises semisolid emulsion stability. This study optimized aminomethyl propanol (AMP) concentration (0%, 0.2%, and 0.5%) as a neutralizing agent in a carbomer-based topical analgesic cream, evaluating its effects on physicochemical properties, active pharmaceutical ingredient (API) consistency, stability, and user acceptability. Physicochemical evaluations revealed that increasing AMP concentration enhanced polymer expansion, directly elevating formulation pH and viscosity. The 0% AMP formulation (F1) remained highly acidic (pH 3.1) with low viscosity (22,278 cP), leading to initial phase separation and high content uniformity deviation, particularly for menthol (137.60%). Conversely, 0.5% AMP (F3) exhibited a firm structural integrity with high viscosity (115,555 cP) but resulted in an alkaline pH (7.4) and a drop in capsaicin levels after storage. The 0.2% AMP formulation (F2) demonstrated the most balanced performance, featuring a skin-compatible pH of 5.5, ideal density (1.11 g/mL), stable viscosity (91,165 cP), and uniform API distribution closest to specifications (112.60% menthol, 111.52% methyl salicylate, and 100.50% capsaicin). Furthermore, during accelerated stability testing using a cycling test (6 cycles alternating between 4°C and 40°C), F2 maintained excellent homogeneity without phase separation or drastic viscosity drops. In the hedonic test with 20 panelists, F2 achieved the highest overall acceptability score (214), particularly for its superior texture and smoothness. Therefore, 0.2% AMP was identified as the optimal concentration for the developed formulation.
Copyrights © 2026